ANRO has been granted a new patent
Feb 19, 2025, 11:42 PM
-15.94%
What does ANRO do
Alto Neuroscience, a clinical-stage biopharmaceutical company based in Los Altos, California, focuses on developing psychiatric drugs using its Precision Psychiatry Platform. The company has five clinical-stage assets targeting depression and schizophrenia, with an IPO on February 2, 2024.
ANRO filed a patent for "method of treatment and selection of patients benefiting from agomelatine based on eeg measurements" on Thu, August 10, 2023.
📡️ Health Care
Patents
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.